These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 26890818)
1. Serum anti-lysozyme is associated with disease activity of Behçet's disease. Park JS; Kang MI; Ha YJ; Song JJ; Park YB; Lee SK; Lee SW Int J Rheum Dis; 2017 Feb; 20(2):261-268. PubMed ID: 26890818 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein. Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703 [TBL] [Abstract][Full Text] [Related]
3. Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878 [TBL] [Abstract][Full Text] [Related]
4. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity? Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373 [TBL] [Abstract][Full Text] [Related]
5. Increased serum interleukin-32 levels in patients with Behçet's disease. Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461 [TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations. Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507 [TBL] [Abstract][Full Text] [Related]
7. Serum PLR and LMR in Behçet's disease: Can they show the disease activity? Jiang Y; Zang M; Li S Medicine (Baltimore); 2017 May; 96(21):e6981. PubMed ID: 28538403 [TBL] [Abstract][Full Text] [Related]
8. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters. Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990 [TBL] [Abstract][Full Text] [Related]
9. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease. Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease. Balkarli A; Kucuk A; Babur H; Erbasan F Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734 [TBL] [Abstract][Full Text] [Related]
11. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease. Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175 [TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease. Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281 [TBL] [Abstract][Full Text] [Related]
13. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study. Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528 [TBL] [Abstract][Full Text] [Related]
14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity. Melikoglu M; Melikoglu MA Rheumatol Int; 2013 May; 33(5):1219-22. PubMed ID: 23052486 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity. Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939 [TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. Adam B; Calikoglu E J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143 [TBL] [Abstract][Full Text] [Related]
18. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Triolo G; Accardo-Palumbo A; Triolo G; Carbone MC; Ferrante A; Giardina E Clin Immunol; 1999 Jun; 91(3):330-7. PubMed ID: 10370379 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement. Bassyouni IH; Gamal S; Talaat RM; Siam I Mod Rheumatol; 2014 Mar; 24(2):316-20. PubMed ID: 24593207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]